Recombinant Enzymes for Cell-Free Cannabinoid Biosynthesis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing pharmaceutical-grade cannabinoids face challenges due to the high structural similarity of contaminating cannabinoids and variability in cannabinoid composition, making it difficult to isolate both high-abundance and rare cannabinoids, and are environmentally unsustainable.
Innovation Solution
A recombinant polypeptide with specific mutations and a biosynthetic pathway that includes enzymes to convert glucose into geranyl pyrophosphate, enabling the prenylation of substrates to produce cannabinoids such as cannabigerolic acid and cannabidiolic acid through a cell-free system, bypassing the need for plant-based extraction.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If plant-based extraction methods are used to produce cannabinoids, then pharmaceutical-grade purity can be achieved, but the process becomes extremely difficult and costly due to high structural similarity of contaminating cannabinoids and variability in composition
Solution Approach 1:
The patent extracts the cannabinoid biosynthetic pathway from the complex plant system and implements it in a simplified heterologous expression system. By taking out only the essential enzymes (CBGA synthase, CBDAS, THCAS) and their substrates, the method eliminates the contamination problem inherent in plant extraction while maintaining product purity.
Solution Approach 2:
The cannabinoid production pathway is segmented into discrete enzymatic steps that can be independently expressed and optimized. The patent divides the complex plant metabolic pathway into separate gene expressions for each enzyme, allowing precise control over substrate availability and product formation, thereby simplifying manufacturing.
2Productivity
If traditional cannabis farming practices are used, then cannabinoids can be produced, but serious environmental challenges arise
Solution Approach 1:
The patent replaces the mechanical/biological farming system with an in vitro enzymatic system. By substituting whole-plant cultivation with purified enzyme reactions in controlled buffers, the method eliminates agricultural environmental impacts while maintaining high productivity through optimized reaction conditions.
Solution Approach 2:
The patent uses recombinant enzymes as intermediaries to transfer the cannabinoid synthesis function from plants to an in vitro system. These enzyme intermediaries catalyze the same reactions as in plants but in a controlled, environmentally benign setting, decoupling production from agricultural practices.
3Quantity of substance
If rare cannabinoids are targeted for isolation, then high-value products can be obtained, but the difficulty of isolation increases significantly due to low natural abundance
Solution Approach 1:
The patent performs preliminary action by engineering the expression system to produce high concentrations of specific cannabinoid precursors (CBGA, CBGVA) before the final conversion step. By accumulating substrates in advance through controlled enzyme expression, the system ensures high abundance of target cannabinoids when needed, eliminating isolation difficulties.
Solution Approach 2:
The patent changes key parameters including enzyme expression levels, substrate concentrations, and reaction conditions to optimize production of rare cannabinoids. By adjusting these parameters, the system can produce high abundances of specific cannabinoids that would be rare in plants, making isolation trivial.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for high-yield, cost-effective production of cannabinoids with improved specificity and reduced environmental impact, overcoming the limitations of traditional methods by using a modular and flexible synthetic biochemistry platform.
Implementation Method 1
a recombinant polypeptide with specific mutations and a biosynthetic pathway that includes enzymes to convert glucose into geranyl pyrophosphate, enabling the prenymation of substrates to produce cannabinoids
Data Source
AI summary
Provided is an enzyme useful for prenylation and recombinant pathways for the production of cannabinoids, cannabinoid precursors and other prenylated chemicals in a cell free system as well and recombinant microorganisms that catalyze the reactions.